Home » Medical Devices » France Peripheral Vascular Devices Market

France Peripheral Vascular Devices Market By Type (Angioplasty Balloons, Angioplasty Stents, Catheters, Guidewires, Others); By End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
France Peripheral Vascular Devices Market Size 2023	USD 372.51 million
France Peripheral Vascular Devices Market, CAGR	6.33%
France Peripheral Vascular Devices Market Size 2032	USD 608.81 million

Market Overview

The France peripheral vascular devices market is projected to grow from USD 372.51 million in 2023 to USD 608.81 million by 2032, with a compound annual growth rate (CAGR) of 6.33%.

The France peripheral vascular devices market is driven by the rising prevalence of vascular diseases, an aging population, and increasing healthcare investments. Technological advancements in minimally invasive procedures and the growing adoption of advanced diagnostic tools are also boosting market growth. The rising demand for innovative and effective treatments for peripheral artery disease (PAD) and deep vein thrombosis (DVT) is further contributing to the market’s expansion. Moreover, the growing awareness of the importance of early diagnosis and treatment, coupled with supportive government initiatives, is accelerating the adoption of peripheral vascular devices. Trends such as the integration of smart technologies in devices for better monitoring and management of vascular conditions are gaining traction. Additionally, the expansion of healthcare infrastructure and a shift toward outpatient procedures are anticipated to create significant opportunities for market players, leading to sustained growth over the forecast period.

The France peripheral vascular devices market is characterized by regional differences in demand and healthcare infrastructure. Key players such as Medtronic plc, Becton, Dickinson and Company, and Boston Scientific Corporation have a strong presence across the country, particularly in major healthcare hubs like Paris and Lyon, where advanced medical technologies are more widely adopted. These companies dominate the market with their extensive portfolios of innovative vascular devices, including stents, angioplasty balloons, and guidewires. Additionally, local players such as Biotronik SE & Co. KG and Terumo Corporation contribute significantly to the market by offering specialized solutions tailored to the needs of the French healthcare system. The increasing number of vascular care centers and a focus on minimally invasive treatments in regions like Northern and Southern France further drive the adoption of these devices. The market is expected to expand as key players continue to innovate and collaborate with local healthcare providers.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The France peripheral vascular devices market was valued at USD 372.51 million in 2023 and is projected to reach USD 608.81 million by 2032, growing at a CAGR of 6.33%.
Rising prevalence of vascular diseases, especially in the aging population, is driving the demand for peripheral vascular devices.
Technological advancements, such as minimally invasive devices and smart technology integration, are boosting market growth.
Increasing awareness about early diagnosis and the shift toward outpatient treatments are key trends in the market.
Competitive landscape is dominated by major players like Medtronic plc, Boston Scientific Corporation, and Becton, Dickinson and Company, with a focus on product innovation.
High cost of advanced devices and regulatory challenges, such as approval delays and reimbursement policies, are restraining market growth.
Regional growth is significant in Northern and Southern France, driven by advanced healthcare infrastructure and increasing specialty clinics.

Market Drivers

Supportive Healthcare Policies and Investments

The French government’s focus on improving healthcare infrastructure and its commitment to enhancing vascular care services further drives the market. Increased healthcare spending and funding for innovative medical technologies, along with favorable reimbursement policies, are creating an enabling environment for the adoption of advanced peripheral vascular devices. For example, the Health Innovation Plan 2030 allocates €7.5 billion to support healthcare innovations, including advanced medical technologies. The expansion of healthcare facilities and adoption of modern treatment protocols also contribute to the growth of the market, ensuring continued demand for cutting-edge vascular treatment options.

Growing Awareness and Early Diagnosis

The growing awareness of vascular health and the importance of early diagnosis plays a significant role in driving demand for peripheral vascular devices in France. Public health campaigns, along with an increasing emphasis on preventive healthcare, are leading to earlier detection of vascular diseases. For instance, the European Society of Cardiology has launched initiatives to promote cardiovascular health and early diagnosis of vascular diseases. This shift towards early intervention, combined with the availability of advanced diagnostic tools, is expanding the need for effective treatment devices, thus propelling market growth.

Rising Prevalence of Vascular Diseases

The increasing prevalence of peripheral artery disease (PAD) and deep vein thrombosis (DVT) in France is a key driver for the growth of the peripheral vascular devices market. Factors such as an aging population, unhealthy lifestyles, smoking, and diabetes contribute to the growing incidence of these vascular conditions. As the number of patients needing treatment for these diseases rises, the demand for peripheral vascular devices, such as stents, catheters, and atherectomy devices, continues to increase.

Technological Advancements in Treatment Options

Technological innovations in peripheral vascular devices are fueling market growth by providing less invasive, more effective treatment options. Advances such as drug-eluting stents, biodegradable stents, and new catheter designs enhance the precision, safety, and efficiency of procedures. These innovations improve patient outcomes and reduce recovery times, making them more appealing to both healthcare providers and patients, further boosting the market’s expansion.

Market Trends

Integration of Smart Technologies

One of the key trends in the France peripheral vascular devices market is the integration of smart technologies. Devices equipped with sensors, connectivity features, and data analytics are enabling healthcare providers to monitor and manage vascular conditions more effectively. For instance, the French Ministry of Health has reported that the adoption of smart health cards, such as the Carte Vitale, has significantly improved patient data management and healthcare delivery. These smart devices provide real-time data on patient health, allowing for timely interventions and better treatment outcomes. The growing adoption of remote monitoring and telemedicine in vascular care is likely to increase as healthcare systems focus on improving patient management.

Shift Toward Minimally Invasive Procedures

Minimally invasive procedures are becoming increasingly popular in the treatment of peripheral vascular diseases in France. Patients and healthcare providers are opting for procedures that involve smaller incisions, reduced risk of complications, and shorter recovery times. This shift is driving demand for advanced peripheral vascular devices such as angioplasty balloons, stents, and guidewires that facilitate less invasive treatments. As more patients seek quicker and safer alternatives to traditional surgeries, the market for these devices continues to grow.

Personalized Treatment Solutions

There is a growing trend toward personalized treatment solutions in the peripheral vascular devices market in France. Medical professionals are increasingly tailoring treatments based on individual patient characteristics such as genetics, underlying conditions, and severity of vascular disease. Customized vascular devices designed for specific needs are gaining traction, enhancing the effectiveness of treatments and improving patient satisfaction. This trend reflects the broader movement in healthcare towards more patient-centered care, which is driving innovation in the peripheral vascular device market.

Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure in France is another key trend contributing to the growth of the peripheral vascular devices market. The increasing number of specialized vascular centers and hospitals is providing patients with better access to advanced treatment options. Moreover, the rising demand for outpatient and day-surgery procedures is encouraging healthcare facilities to invest in state-of-the-art equipment. This trend is expected to further support the adoption of advanced peripheral vascular devices, thereby driving market growth over the forecast period.

Market Challenges Analysis

High Cost of Advanced Devices

One of the primary challenges facing the France peripheral vascular devices market is the high cost of advanced devices. Innovative devices such as drug-eluting stents, bioresorbable stents, and advanced catheters come with substantial price tags, making them less accessible, particularly in cost-sensitive healthcare settings. This high cost can limit the adoption of the latest technologies, especially in public healthcare systems with budget constraints. Additionally, while these advanced devices offer superior treatment outcomes, the initial investment can be a barrier for many healthcare providers, hindering their widespread use across the country.

Regulatory and Reimbursement Issues

The regulatory and reimbursement landscape for peripheral vascular devices in France presents another challenge to market growth. Strict regulatory requirements for device approval, including clinical trials and compliance with European Union regulations, can lead to lengthy product launch timelines and higher costs for manufacturers. For instance, obtaining CE Mark approval for a new medical device in Europe can take several months and cost upwards of €50,000. Moreover, reimbursement policies vary across regions and can be restrictive, limiting patient access to certain high-tech devices. Inconsistent reimbursement rates and delays in policy changes can hinder the adoption of innovative devices, creating uncertainty for both manufacturers and healthcare providers. This regulatory complexity can impede market expansion, particularly for smaller companies seeking to enter the French market.

Market Opportunities

Expanding Aging Population and Increasing Healthcare Demand

The expanding aging population in France presents a significant market opportunity for peripheral vascular devices. As individuals age, the prevalence of vascular diseases such as peripheral artery disease (PAD) and deep vein thrombosis (DVT) increases, driving demand for effective treatment solutions. With the aging demographic, healthcare systems are focusing on improving vascular care, creating a growing need for advanced devices. Manufacturers can capitalize on this trend by developing innovative, minimally invasive devices tailored to the needs of older patients. The rise in chronic conditions associated with aging further expands the opportunity for market players to offer targeted solutions for better disease management and improved patient outcomes.

Technological Innovation and Healthcare Investment

Another key opportunity lies in the continued technological advancements in peripheral vascular devices. The integration of smart technologies, including sensors, data analytics, and remote monitoring, is opening new avenues for device innovation. These technologies enable healthcare providers to offer more personalized and effective treatments, which enhances patient satisfaction and drives demand for cutting-edge devices. Moreover, increasing investment in healthcare infrastructure in France is creating favorable conditions for the adoption of advanced vascular devices. The government’s focus on modernizing healthcare services and expanding specialized vascular centers presents growth opportunities for both established and new market players, providing them with the resources needed to meet rising demand and improve treatment options.

Market Segmentation Analysis:

By Type:

The France peripheral vascular devices market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. Among these, angioplasty balloons and angioplasty stents are leading segments due to their widespread use in treating peripheral artery disease (PAD) and other vascular conditions. Angioplasty balloons are used to open narrowed or blocked arteries, while angioplasty stents help to maintain the arteries’ patency after ballooning. Catheters and guidewires are essential for guiding these devices to the target area and ensuring precise procedures. Other devices, such as atherectomy tools and thrombectomy devices, are also gaining traction due to advancements in minimally invasive procedures. These devices are increasingly used in combination with one another to enhance treatment outcomes and improve patient recovery times, which further drives demand in this segment.

By End-user:

The end-user segmentation of the France peripheral vascular devices market includes hospitals, ambulatory surgical centers, and specialty clinics. Hospitals are the largest end-users due to their comprehensive capabilities to handle complex vascular procedures and treat high-risk patients. However, ambulatory surgical centers are rapidly gaining market share due to their cost-effectiveness, shorter procedure times, and growing preference for outpatient treatments. Specialty clinics, particularly those focusing on vascular and cardiovascular care, are also emerging as important end-users as the demand for targeted vascular treatments increases. The shift towards outpatient and minimally invasive treatments is contributing to the growth of ambulatory surgical centers and specialty clinics, driving the overall demand for peripheral vascular devices.

Segments:

Based on Type:

Angioplasty Balloons
Angioplasty Stents
Catheters
Guidewires
Others

Based on End-user:

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

Based on the Geography:

Northern France
Southern France
Eastern France
Western France

Regional Analysis

Northern France

Northern France holds a significant share of the France peripheral vascular devices market, accounting for approximately 30% of the total market. This region is home to some of the largest healthcare centers and hospitals in the country, driving demand for advanced vascular devices. The high prevalence of vascular diseases in urban areas, combined with the region’s advanced healthcare infrastructure, contributes to its market dominance. Additionally, Northern France benefits from the presence of several medical device manufacturers and distributors, further boosting the availability and adoption of peripheral vascular devices. As the healthcare system in this region continues to invest in modern technologies and minimally invasive treatments, the demand for peripheral vascular devices is expected to remain strong.

Southern France

Southern France, on the other hand, holds around 28% of the market share, benefiting from a growing elderly population and an increasing incidence of vascular diseases. This region, known for its high quality of healthcare services and expanding specialty clinics, has witnessed rising demand for peripheral vascular devices, particularly angioplasty stents and catheters. The trend toward outpatient treatments and the growing number of vascular centers further contribute to the region’s growth. Moreover, Southern France’s strategic location near Mediterranean healthcare hubs encourages the adoption of cutting-edge medical technologies, further propelling market growth. This region’s focus on patient-centric care and medical tourism also plays a role in enhancing the demand for vascular devices.

Eastern France

Eastern France represents a smaller but rapidly growing segment of the market, holding approximately 21% of the total market share. This region has seen significant developments in vascular care, with an increasing number of specialized vascular treatment centers and hospitals. As the prevalence of vascular diseases rises in Eastern France, particularly in aging populations, there is an expanding need for innovative peripheral vascular devices. The demand is particularly strong in cities such as Strasbourg and Lyon, where advanced medical technology is more readily available. The region also benefits from proximity to other European healthcare markets, fostering collaboration and knowledge exchange that supports the growth of the peripheral vascular devices market.

Western France

Western France, while representing a smaller portion of the market at around 21%, is experiencing notable growth, driven by improvements in healthcare infrastructure and the rising demand for minimally invasive treatments. The region has a growing number of hospitals and specialized clinics focusing on vascular care, providing a favorable environment for the adoption of advanced peripheral vascular devices. Furthermore, Western France’s emphasis on preventative healthcare and early diagnosis is contributing to the increasing demand for vascular treatment options. With a larger focus on reducing healthcare costs and improving patient outcomes, Western France is becoming an important region for the expansion of the peripheral vascular devices market.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Medtronic plc
Becton, Dickinson and Company
Biotronik SE & Co. KG
Koninklijke Philips N.V.
Boston Scientific Corporation
Terumo Corporation
Cook Medical
Straub Medical AG
Eurocor Tech GmbH
AngioDynamics, Inc.

Competitive Analysis

The competitive landscape of the France peripheral vascular devices market is led by prominent players like Medtronic plc, Becton, Dickinson and Company, Biotronik SE & Co. KG, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Cook Medical, Straub Medical AG, Eurocor Tech GmbH, and AngioDynamics, Inc. Leading players focus on expanding their product portfolios, particularly in advanced vascular devices such as angioplasty stents, balloons, and guidewires. They invest heavily in research and development to introduce cutting-edge technologies, like minimally invasive devices and smart technology integration, which improve patient outcomes and procedure efficiency. For instance, Becton, Dickinson and Company (BD) has initiated the AGILITY study to evaluate the safety and effectiveness of the BD Vascular Covered Stent for treating PAD. Competition is further driven by companies seeking to capture the growing demand for peripheral vascular devices in France, particularly in urban centers with advanced healthcare infrastructure. These companies focus on enhancing their distribution networks to reach key healthcare facilities, such as hospitals and specialty clinics. With a growing emphasis on outpatient and minimally invasive procedures, the market is witnessing an increase in partnerships between device manufacturers and healthcare providers. However, challenges such as regulatory hurdles and reimbursement policies continue to affect the competitive dynamics. Companies are striving to navigate these challenges while maintaining product quality and affordability to remain competitive in the market. Overall, the competition is intensifying as the market for peripheral vascular devices continues to expand in response to rising demand for advanced healthcare solutions.

Recent Developments

In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD’s ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.

Market Concentration & Characteristics

The market concentration of France’s peripheral vascular devices sector is moderate, with a mix of global leaders and regional players. While large multinational companies dominate the market, they face competition from specialized local manufacturers offering innovative solutions. The industry is characterized by significant product differentiation, as leading companies continually innovate to offer advanced devices such as drug-eluting stents, bioresorbable stents, and smart catheters, which cater to the growing demand for minimally invasive and personalized treatments. The presence of strong research and development capabilities and extensive distribution networks enhances the competitiveness of these players, allowing them to expand their reach across France. The market is also influenced by a trend toward consolidation, with larger companies acquiring smaller firms to diversify their product portfolios and strengthen their market position. This consolidation is aimed at enhancing operational efficiencies, streamlining product offerings, and gaining access to new technologies. Furthermore, regulatory compliance, technological advancements, and partnerships with healthcare providers are key characteristics that define the competitive environment. Companies are also focusing on strengthening relationships with hospitals, specialty clinics, and ambulatory surgical centers to maintain market leadership. Despite high competition, the market offers significant growth opportunities driven by the increasing prevalence of vascular diseases and the shift towards outpatient and minimally invasive treatments.

Report Coverage

The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The France peripheral vascular devices market is expected to continue growing due to the aging population and increasing incidence of vascular diseases.
Technological advancements in minimally invasive devices will drive market growth by improving patient outcomes and reducing recovery times.
The demand for drug-eluting stents and bioresorbable devices will increase as more patients seek long-term solutions for peripheral artery disease.
Expansion of outpatient care and ambulatory surgical centers will contribute to higher adoption of peripheral vascular devices.
There will be a rise in collaborations between manufacturers and healthcare providers to improve access to advanced vascular treatments.
Increasing investment in research and development will lead to the introduction of more innovative and cost-effective devices.
Enhanced regulatory approvals and reimbursement policies are likely to facilitate wider adoption of new technologies.
Key players will focus on regional expansion, particularly in underserved areas, to capture untapped market potential.
The trend towards personalized medicine will influence the development of vascular devices tailored to individual patient needs.
Competition will intensify as companies strive to lead the market through continuous innovation and strategic partnerships.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Peripheral Vascular Devices Market Snapshot 21

2.1.1. France Peripheral Vascular Devices Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : PERIPHERAL VASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Increasing prevalence of peripheral artery disease and other vascular conditions 25

4.2.2. Technological advancements in minimally invasive procedures 26

4.3. Market Restraints 27

4.3.1. High cost of peripheral vascular devices and associated procedures 27

4.4. Market Opportunities 28

4.4.1. Growing demand for peripheral vascular devices in emerging economies 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by France 31

5.1.1. France Peripheral Vascular Devices Market Import Volume/Revenue, By France, 2018 – 2023 31

5.2. Export Analysis by France 32

5.2.1. France Peripheral Vascular Devices Market Export Volume/Revenue, By France, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by France 33

6.1.1. France Peripheral Vascular Devices Market Demand Volume/Revenue, By France, 2018 – 2023 33

6.2. Supply Analysis by France 34

6.2.1. France Peripheral Vascular Devices Market Supply Volume/Revenue, By France, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by France 35

7.1.1. France Peripheral Vascular Devices Market Production Volume/Revenue, By France, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. France Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36

8.1.2. France Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. France Peripheral Vascular Devices Market: Company Market Share, by Volume, 2023 40

11.2.2. France Peripheral Vascular Devices Market: Company Market Share, by Revenue, 2023 41

11.2.3. France Peripheral Vascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. France Peripheral Vascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. France Peripheral Vascular Devices Market Company Volume Market Share, 2023 43

11.4. France Peripheral Vascular Devices Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

France Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : PERIPHERAL VASCULAR DEVICES MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Peripheral Vascular Devices Market Overview, by Type Segment 49

13.1.1. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Angioplasty Balloons 53

13.3. Angioplasty Stents 54

13.4. Catheters 55

13.5. Guidewires 56

13.6. Others 57

CHAPTER NO. 14 : PERIPHERAL VASCULAR DEVICES MARKET – BY END-USER SEGMENT ANALYSIS 58

14.1. Peripheral Vascular Devices Market Overview, by End-user Segment 58

14.1.1. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59

14.1.2. Peripheral Vascular Devices Market Attractiveness Analysis, By End-user 60

14.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 60

14.1.4. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61

14.2. Hospitals 62

14.3. Ambulatory Surgical Centers 63

14.4. Specialty Clinics 64

CHAPTER NO. 15 : PERIPHERAL VASCULAR DEVICES MARKET – FRANCE ANALYSIS 65

15.1. Type 65

15.1.1. France Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65

15.2. France Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65

15.3. End-user 66

15.3.1. France Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66

15.3.2. France Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66

CHAPTER NO. 16 : COMPANY PROFILES 67

16.1. Medtronic plc 67

16.1.1. Company Overview 67

16.1.2. Product Portfolio 67

16.1.3. Swot Analysis 67

16.1.4. Business Strategy 68

16.1.5. Financial Overview 68

16.2. Becton, Dickinson and Company 69

16.3. Biotronik SE & Co. KG 69

16.4. Koninklijke Philips N.V. 69

16.5. Boston Scientific Corporation 69

16.6. Terumo Corporation 69

16.7. Cook Medical 69

16.8. Straub Medical AG 69

16.9. Eurocor Tech GmbH 69

16.10. AngioDynamics, Inc. 69

List of Figures

FIG NO. 1. France Peripheral Vascular Devices Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for France Peripheral Vascular Devices Market 29

FIG NO. 3. France Peripheral Vascular Devices Market Import Volume/Revenue, By France, 2018 – 2023 31

FIG NO. 4. France Peripheral Vascular Devices Market Export Volume/Revenue, By France, 2018 – 2023 32

FIG NO. 5. France Peripheral Vascular Devices Market Demand Volume/Revenue, By France, 2018 – 2023 33

FIG NO. 6. France Peripheral Vascular Devices Market Supply Volume/Revenue, By France, 2018 – 2023 34

FIG NO. 7. France Peripheral Vascular Devices Market Production Volume/Revenue, By France, 2018 – 2023 35

FIG NO. 8. France Peripheral Vascular Devices Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for France Peripheral Vascular Devices Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Peripheral Vascular Devices Market – Company Volume Market Share, 2023 43

FIG NO. 18. Peripheral Vascular Devices Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Peripheral Vascular Devices Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Peripheral Vascular Devices Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. France Peripheral Vascular Devices Market for Angioplasty Balloons, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. France Peripheral Vascular Devices Market for Angioplasty Stents, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. France Peripheral Vascular Devices Market for Catheters, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. France Peripheral Vascular Devices Market for Guidewires, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. France Peripheral Vascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. Peripheral Vascular Devices Market Revenue Share, By End-user, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By End-user 60

FIG NO. 30. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 60

FIG NO. 31. Peripheral Vascular Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61

FIG NO. 32. France Peripheral Vascular Devices Market for Hospitals, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. France Peripheral Vascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. France Peripheral Vascular Devices Market for Specialty Clinics, Revenue (USD Million) 2018 – 2032 64

List of Tables

TABLE NO. 1. : France Peripheral Vascular Devices Market: Snapshot 21

TABLE NO. 2. : Drivers for the Peripheral Vascular Devices Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Peripheral Vascular Devices Market: Impact Analysis 27

TABLE NO. 4. : France Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : France Peripheral Vascular Devices Market Revenue, By Type, 2018 – 2023 (USD Million) 65

TABLE NO. 7. : France Peripheral Vascular Devices Market Revenue, By Type, 2024 – 2032 (USD Million) 65

TABLE NO. 8. : France Peripheral Vascular Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 66

TABLE NO. 9. : France Peripheral Vascular Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 66

Frequently Asked Questions

What is the current size of the France Peripheral Vascular Devices market?

The France peripheral vascular devices market was valued at USD 372.51 million in 2023 and is projected to reach USD 608.81 million by 2032, growing at a compound annual growth rate (CAGR) of 6.33%.

What factors are driving the growth of the France Peripheral Vascular Devices market?

The market is driven by the rising prevalence of vascular diseases, an aging population, increasing healthcare investments, and technological advancements in minimally invasive procedures. Growing awareness about early diagnosis, supportive government initiatives, and the adoption of smart technologies in devices also contribute to market growth.

What are the key segments within the France Peripheral Vascular Devices market?

The market is segmented by type into angioplasty balloons, angioplasty stents, catheters, guidewires, and others. It is also divided by end-user into hospitals, ambulatory surgical centers, and specialty clinics. Geographically, the market includes Northern, Southern, Eastern, and Western France.

What are some challenges faced by the France Peripheral Vascular Devices market?

Key challenges include the high cost of advanced devices, which can limit accessibility, and regulatory hurdles that lead to lengthy approval processes. Inconsistent reimbursement policies also pose a barrier to the widespread adoption of innovative technologies.

Who are the major players in the France Peripheral Vascular Devices market?

Prominent players include Medtronic plc, Becton, Dickinson and Company, Biotronik SE & Co. KG, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Cook Medical, Straub Medical AG, Eurocor Tech GmbH, and AngioDynamics, Inc. These companies are known for their innovative products and strategic partnerships.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –